Joseph G. Rogers, M.D., Chief Medical Officer of Duke University Health System and Professor of Medicine in Cardiology at Duke University School of Medicine, has been named President and Chief Executive Officer of the Texas Heart Institute in Houston, Texas.
Texas Heart Institute (THI) Board Chairman Eric D. Wade announced Rogers’ appointment following a national search. “Dr. Rogers possesses the skillful leadership and expertise that the Texas Heart Institute needs during a pivotal moment in its history. With the recent launch of the Texas Heart Medical Group, seminal discoveries in cardiovascular care in the COVID era, and our responsibility to educate and train the best and brightest fellows in cardiology, Dr. Rogers brings experience to lead THI’s mission to reduce the devastating toll of cardiovascular disease through innovative programs in research, education, and improved patient care,” said Wade.
Text Get the tools to succeed
Sign Up Free
“I am honored to have been chosen to lead THI, arguably the most storied and influential cardiovascular institute in the United States. I look forward to building upon the strong foundation laid by the teams of clinicians, researchers, and educators at THI to increase the Institute’s impact on cardiovascular disease,” stated Dr. Rogers.
At Duke University and in his earlier career at Washington University, where Rogers received training as both a clinical and research fellow, he led clinical program development in transplant, heart failure, and mechanical circulatory support. At Washington University, Rogers oversaw and expanded the cardiac transplant program, developed the disease management program, and started its LVAD program. At Duke, Rogers led its heart failure program from 2004 to 2013. He served as Vice Chief for Clinical Affairs in Duke’s Division of Cardiology when it was ranked number 5 in the country.
Today, Rogers serves as the Chief Medical Officer at Duke’s preeminent health care system, which educates and trains thousands of physicians and health care professionals. It attracts more than 69,000 annual patient stays and two million outpatient visits and is ranked as a top 20 hospital in the country. Rogers has authored more than 230 publications and has maintained a research portfolio with NIH funding throughout his career. He remains deeply involved in leading-edge LVAD research, including serving as the principal investigator on several national studies.
In addition to clinical and research roles, Dr. Rogers also oversees graduate medical education, with more than 1000 trainees currently enrolled. He has led initiatives to guide quality care and safety, and he has focused on the development of diversity and inclusion programs. He understands the importance of outreach programs, and community engagement.
Rogers is expected to begin his new duties on May 17, 2021.
Michael MK
Senior Editor & Writer
It will be the largest urban solar farm in the nation built on a landfill
The husband and wife owned and operated group homes in which Medicare beneficiaries lived
Police discover $2 million worth of crystal meth inside of a home in Harris County
Avian influenza can cause severe illness and death in many bird species
Reliant named the Official Energy Provider of the Houston Astros
Stats
Elapsed time: 0.6483 seconds
Memory useage: 2.78MB
V2.geronimo